Invesaro

Stocks QTWO Financial statements

Financial statements

Q2 Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Q2 Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue150194241315403499566625696795
Cost of revenue77.499.5122162228274309322342365
Gross profit72.894.5119153175225256303354430
Research and development32.540.351.376.397.4117130137143154
Selling and marketing36.341.248.163.972.385.6108110106106
General and administrative3237.24556.770.977.990.2110123126
Operating expenses109121151220274303361389397390
Operating income-35.7-26.9-31.9-66.7-99.8-78-105-86.1-42.339.9
Interest expense4.644.744.93
Interest income0.360.552.813.671.211.485.3610.1
Other non-operating income-0.210.43-7.35-16.6-36.4-33.1-1.3124.211.414.8
Pre-tax income-35.9-26.5-39.2-83.4-136-111-106-61.8-30.954.7
Income tax0.43-0.31-3.8-12.51.421.642.913.567.682.72
Net income-36.4-26.2-35.4-70.9-138-113-109-65.4-38.552
EBITDA-23.5-12-15-38.3-48-23.2-43.1-14.426.593.3
EPS, basic-0.92-0.63-0.83-1.53-2.65-2.00-1.90-1.12-0.640.84
EPS, diluted-0.92-0.63-0.83-1.53-2.65-2.00-1.90-1.12-0.640.80
Shares, basic (weighted)39.641.242.846.25256.457.358.460.162.2
Shares, diluted (weighted)39.641.242.846.25256.457.358.460.165.1

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents54.958108100408323200230359368
Short-term investments42.241.76932.313110523494.488.165.1
Receivables12.213.219.722.436.44746.742.942.151.7
Other current assets3.223.123.986.358.8610.510.811.623.528.2
Total current assets126131218186616522531428559556
Property, plant and equipment27.534.53539.349.666.656.741.231.527.8
Lease right-of-use assets35.434.752.339.835.530.427.2
Goodwill12.912.9108462462513513513513513
Intangible assets15.21263.322418516214612294.678.4
Other non-current assets0.531.012.232.322.432.312.262.612.73.15
Total assets2012134641,0091,4171,3851,3501,2011,2951,276
Accounts payable4.237.629.17117.8910.610.119.49.3520.5
Accrued liabilities8.8210.69.3316.322.418.320.716.518.224.6
Deferred revenue30.138.442.557.981.998.7117119138155
Total current liabilities59.268.173.7133146168192192399544
Lease liabilities0.236.136.761.45345.638.333.8
Other non-current liabilities0.360.4417.23.244.14.256.197.9810.49.72
Total liabilities101106305630773815931753777614
Paid-in capital2262603316231,0251,0649821,0751,1841,276
Retained earnings-126-152-172-243-381-494-560-626-664-612
Treasury stock-0.42-0.860
Other comprehensive income-0.05-0.14-0.040.01-0.03-0.14-2.97-1.11-1.87-1.95
Shareholders' equity100107159379643570419448518662
Total equity100107159379643570419448518662
Total liabilities and equity2012134641,0091,4171,3851,3501,2011,2951,276
Shares outstanding40.44243.548.455.656.957.75960.762.7

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-36.4-26.2-35.4-70.9-138-113-109-65.4-38.552
Depreciation and amortization12.214.916.828.551.854.861.771.768.853.4
Stock-based compensation12.620.929.540.550.755.965.279.289.286.9
Deferred income tax0.28-0.35-3.96-13.51.280.540.680.932.50.93
Change in receivables-3.25-0.96-4.680.37-14.6-10.10.294.090.91-9.94
Change in payables0.433.37-0.261.13-2.31.76-0.559.35-9.798.58
Cash from operations3.399.474.60.57-2.9431.136.670.3136201
Capital expenditures-14.3-12.3-13.3-13.9-23.7-19.8-11.1-5.67-6.69-6.81
Acquisitions-0.1-3.82-131-5060-64.7-5.0400
Purchases of investments-40.2-27.7-75.7-27.3-131-124-293-76.9-95.8-94.1
Sales and maturities of investments41.127.948.46431.8149163221104118
Cash from investing-16.5-16.9-171-483-124-65.1-166113-21.1-4.03
Stock issued600195311008.414.37.03
Share buybacks00-5
Cash from financing0.9411.6217476435-51.25.88-15213.3-189
Exchange rate effect0.05-0.17-0.80.18-0.830.05
Net change in cash-12.24.0949.9-6.59308-85.4-12431.71278.51
Free cash flow-11-2.84-8.69-13.3-26.711.325.464.6129195
Interest paid0.220.070.812.854.13.12.892.652.682.85
Income taxes paid0.120.130.250.320.571.030.882.625.883.84

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $56.13 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin57.0%Gross profit / revenue.
Operating margin10.0%Operating income / revenue.
EBITDA margin15.9%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin11.5%Pre-tax income / revenue.
Net margin10.9%Net income / revenue.
FCF margin25.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin26.7%Cash from operations / revenue.
Effective tax rate5.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)14.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)9.5%Net income / average total assets.
Return on invested capital (ROIC)14.7%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue19.2%Research and development expense / revenue.
Stock-based pay / revenue10.0%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.5%Capital expenditures / revenue.
D&A / revenue5.9%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y14.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y12.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y14.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y21.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y18.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y19.7%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y251.5%EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y48.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y76.6%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y50.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y97.1%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y27.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y16.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y0.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-1.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-1.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-2.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y8.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y4.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y4.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.94xCurrent assets / current liabilities.
Quick ratio0.68x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.41x(Cash + short-term investments) / current liabilities.
Liabilities / assets33.6%Total liabilities / total assets.
Working capital-$14.3MCurrent assets - current liabilities.
Goodwill and intangibles / assets60.5%(Goodwill + intangible assets) / total assets.
Tangible book value$57.1MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.87xRevenue / average total assets.
Fixed asset turnover30.4xRevenue / average property, plant and equipment.
Receivables turnover12.0xRevenue / average receivables.
Days sales outstanding30 days365 x average receivables / revenue.
Days payables16 days365 x average accounts payable / cost of revenue.
FCF conversion231.8%Free cash flow / net income, when net income is positive.
Capex / operating cash flow5.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.41Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$12.93Revenue / diluted weighted shares.
FCF per share$3.26Free cash flow / diluted weighted shares.
Operating cash flow per share$3.46Cash from operations / diluted weighted shares.
Book value per share$10.32Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.92Tangible book value / shares outstanding.
Cash per share$1.71(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$3.50BShare price x shares outstanding.
Enterprise value$3.39BMarket cap + total debt - cash - short-term investments.
P/E38.0xMarket cap / net income. Only when net income is positive.
P/S4.14xMarket cap / revenue.
P/B5.44xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book61.3xMarket cap / tangible book value, when positive.
P/FCF16.4xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF15.5xMarket cap / cash from operations, when positive.
EV/Sales4.01xEnterprise value / revenue.
EV/EBIT40.0xEnterprise value / operating income, when both are positive.
EV/EBITDA25.2xEnterprise value / EBITDA, when both are positive.
EV/FCF15.9xEnterprise value / free cash flow, when both are positive.
FCF yield6.1%Free cash flow / market cap.
Earnings yield2.6%Net income / market cap (the inverse of P/E).
What was Q2 Holdings, Inc.'s revenue in fiscal 2025?

Q2 Holdings, Inc. reported revenue of $794.8M for fiscal 2025, 14.1% higher than the year before.

Was Q2 Holdings, Inc. profitable in fiscal 2025?

Yes. Net income was $52.0M, a net margin of 6.5%.

How much free cash flow did Q2 Holdings, Inc. generate in fiscal 2025?

Cash from operations of $201.5M minus capital expenditures of $6.8M left free cash flow of $194.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Q2 Holdings, Inc.